Overview
Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder
Status:
Completed
Completed
Trial end date:
2007-07-01
2007-07-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This extension study is designed to assess the long-tem tolerability and safety of licarbazepine in patients who completed the 6-week double-blind study CLIC477D2303.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Novartis
Criteria
Inclusion Criteria:- written informed consent provided prior to participation in the extension study
- successful completion of study CLIC477D2303
- cooperation and willingness to comply with all study requirements
Exclusion Criteria:
- premature discontinuation from study CLIC477D2303
- failure to comply with study CLIC477D2303